ad 5075 has been researched along with prostaglandin d2 in 1 studies
Studies (ad 5075) | Trials (ad 5075) | Recent Studies (post-2010) (ad 5075) | Studies (prostaglandin d2) | Trials (prostaglandin d2) | Recent Studies (post-2010) (prostaglandin d2) |
---|---|---|---|---|---|
9 | 0 | 0 | 3,454 | 78 | 751 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bansal, VS; Detmers, PA; Somers, EP; Vaidya, S; Wright, SD | 1 |
1 other study(ies) available for ad 5075 and prostaglandin d2
Article | Year |
---|---|
15-Deoxy-Delta12,1412,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; CD18 Antigens; Cell Adhesion; Cyclic AMP; Humans; Neutrophils; Prostaglandin D2; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, Prostaglandin; Respiratory Burst; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |